305 related items for PubMed ID: 16945177
1. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
Sugioka N, Kokuhu T, Okamoto M, Yoshimura N, Ito Y, Shibata N, Takada K.
J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177
[Abstract] [Full Text] [Related]
2. Evolution of the therapeutic drug monitoring of cyclosporine.
Citterio F.
Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
[Abstract] [Full Text] [Related]
3. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
Paydaş S, Balal M, Sertdemir Y, Seyrek N, Karayaylali I.
Ren Fail; 2005 Mar; 27(4):409-13. PubMed ID: 16060128
[Abstract] [Full Text] [Related]
4. Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations.
Isoniemi H, Tikkanen MJ, Ahonen J, Häyry P.
Transpl Int; 1991 Sep; 4(3):130-5. PubMed ID: 1958276
[Abstract] [Full Text] [Related]
5. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
Eguchi A, Takei T, Yoshida T, Tsuchiya K, Nitta K.
Nephrol Dial Transplant; 2010 Jan; 25(1):124-9. PubMed ID: 19740915
[Abstract] [Full Text] [Related]
6. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
Tory R, Sachs-Barrable K, Goshko CB, Hill JS, Wasan KM.
Transplantation; 2009 Jul 15; 88(1):62-8. PubMed ID: 19584682
[Abstract] [Full Text] [Related]
7. Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level.
Takeuchi H, Matsuno N, Hirano T, Toraishi T, Konno O, Nakamura Y, Iwamoto H, Hama K, Unezaki S, Nagao T.
Transplant Proc; 2008 Sep 15; 40(7):2240-2. PubMed ID: 18790203
[Abstract] [Full Text] [Related]
8. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
Cofan F, Cofan M, Campos B, Guerra R, Campistol JM, Oppenheimer F.
Transplant Proc; 2005 Nov 15; 37(9):3791-3. PubMed ID: 16386540
[Abstract] [Full Text] [Related]
9. Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters.
Takeuchi H, Okuyama K, Konno O, Jojima Y, Akashi I, Nakamura Y, Iwamoto H, Hama K, Iwahori T, Uchiyama M, Ashizawa T, Matsuno N, Nagao T, Hirano T, Oka K.
Transplant Proc; 2005 May 15; 37(4):1745-7. PubMed ID: 15919452
[Abstract] [Full Text] [Related]
10. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients.
Ferraresso M, Citterio F, Ghio L, Romagnoli J, Edefonti A, Berardinelli L, Castagneto M.
Transplant Proc; 2004 Nov 15; 36(9):2656-8. PubMed ID: 15621115
[Abstract] [Full Text] [Related]
11. Lipid relation ships in dialysis and renal transplant patients.
Nicholls AJ, Cumming AM, Catto GR, Edward N, Engeset J.
Q J Med; 1981 Nov 15; 50(198):149-60. PubMed ID: 7029600
[Abstract] [Full Text] [Related]
12. Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study.
Busnach G, Stragliotto E, Minetti E, Perego A, Brando B, Broggi ML, Civati G.
J Nephrol; 1998 Nov 15; 11(2):87-93. PubMed ID: 9589380
[Abstract] [Full Text] [Related]
13. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
Kimak E, Ksiazek A, Baranowicz-Gaszczyk I, Solski J.
Ren Fail; 2007 Nov 15; 29(6):705-12. PubMed ID: 17763166
[Abstract] [Full Text] [Related]
14. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
Sukhavasharin N, Praditpornsilpa K, Avihingsanon Y, Kuoatawintu P, O-Charoen R, Kansanabuch T, Tungsanga K, Eiam-Ong S.
J Med Assoc Thai; 2006 Aug 15; 89 Suppl 2():S15-20. PubMed ID: 17044449
[Abstract] [Full Text] [Related]
15. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
Langers P, Cremers SC, den Hartigh J, Rijnbeek EM, Ringers J, Lamers CB, van Hoek B.
Aliment Pharmacol Ther; 2005 Mar 01; 21(5):549-57. PubMed ID: 15740538
[Abstract] [Full Text] [Related]
16. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
Halim MA, Nampoory MR, Johny KV, Donia F, Hamid MH, Said T, Nair MP, Mansour M, Al-Muzairai I, Samhan M, Al-Mousawi M.
Transplant Proc; 2005 Sep 01; 37(7):3019-21. PubMed ID: 16213291
[Abstract] [Full Text] [Related]
17. C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.
Diciolla F, Scolletta S, Berti L, Maccherini M, Federici D, Bernazzali S, Lisi G, Chiavarelli M.
Transplant Proc; 2005 Mar 01; 37(2):1355-9. PubMed ID: 15848719
[Abstract] [Full Text] [Related]
18. Effect of plasma uric acid on pharmacokinetics of cyclosporine A in living-related renal transplant recipients and pharmacokinetic study in rats with experimental hyperuricaemia.
Sugioka N, Takai M, Yoshida K, Yasuda K, Fukushima K, Kokuhu T, Okamoto M, Yoshimura N, Takada K.
J Clin Pharm Ther; 2010 Jun 01; 35(3):323-32. PubMed ID: 20831533
[Abstract] [Full Text] [Related]
19. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
Bunnag S, Vareesangthip K, Ong-ajyooth L.
J Med Assoc Thai; 2006 Aug 01; 89 Suppl 2():S228-34. PubMed ID: 17044476
[Abstract] [Full Text] [Related]
20. [Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].
Martínez Castelao A, Ramos R, Serón D, Gil-Vernet S, Fiol C, Gómez-Gerique N, Yzaguirre MT, Hurtado I, Sabaté I, Alsina J, Grinyó JM.
Nefrologia; 2002 Aug 01; 22(4):364-9. PubMed ID: 12369128
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
